一名重症患者获得性凝血因子V抑制剂
Acquired factor V inhibitor in a critically ill patient.
作者信息
Morris C J, Curry N
机构信息
Department of Anaesthesia, Stoke Mandeville Hospital, Buckinghamshire, UK.
出版信息
Anaesthesia. 2009 Sep;64(9):1014-7. doi: 10.1111/j.1365-2044.2009.05945.x.
Abstract
Acquired inhibitor of factor V is a rare condition with a variety of clinical manifestations, from extremely mild to life threatening haemorrhage. We present a case from our intensive care unit as a reminder of the less common causes of elevated prothombin and activated partial thromboplastin times, and how knowledge of the variable presentation may aid management.
摘要
获得性凝血因子Ⅴ抑制物是一种罕见疾病，有多种临床表现，从极其轻微到危及生命的出血。我们展示了来自我们重症监护病房的一个病例，以提醒人们注意凝血酶原时间和活化部分凝血活酶时间升高的较不常见原因，以及对其多样表现的了解如何有助于治疗。
相似文献
1
Acquired factor V inhibitor in a critically ill patient.
Anaesthesia. 2009 Sep;64(9):1014-7. doi: 10.1111/j.1365-2044.2009.05945.x.
2
Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays.
Blood Coagul Fibrinolysis. 2006 Oct;17(7):593-7. doi: 10.1097/01.mbc.0000245297.64644.ee.
3
[Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
Hamostaseologie. 2007 Aug;27(3):188-90.
4
Acquired factor V inhibitor in systemic vasculitis.
Int J Rheum Dis. 2012 Apr;15(2):e19-22. doi: 10.1111/j.1756-185X.2011.01670.x. Epub 2011 Sep 21.
5
A novel compensating mechanism for homozygous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor V.
Br J Haematol. 2010 Oct;151(2):198-200. doi: 10.1111/j.1365-2141.2010.08336.x.
6
An acquired factor V inhibitor: clinical and laboratory features.
J Med. 1999;30(5-6):357-66.
7
Factor V inhibitor developing after liver transplantation in a 3-year-old child.
Pediatrics. 1991 Jul;88(1):156-9.
8
A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors.
Int J Hematol. 2018 Aug;108(2):145-150. doi: 10.1007/s12185-018-2453-z. Epub 2018 Apr 2.
9
Acquired Factor V Deficiency Associated with CFPM Administration.
Clin Lab. 2019 Oct 1;65(10). doi: 10.7754/Clin.Lab.2019.190240.
10
Acquired factor V inhibitor.
Intern Med J. 2010 Sep;40(9):667-8. doi: 10.1111/j.1445-5994.2010.02297.x.
引用本文的文献
1
Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement.
Pathol Oncol Res. 2023 Jun 2;29:1611250. doi: 10.3389/pore.2023.1611250. eCollection 2023.
2
Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog.
J Vet Intern Med. 2020 Sep;34(5):2096-2100. doi: 10.1111/jvim.15845. Epub 2020 Jul 20.
3
Acquired factor V inhibitors: a systematic review.
J Thromb Thrombolysis. 2011 May;31(4):449-57. doi: 10.1007/s11239-010-0529-6.
Zotero 插件